Merck & Co., Inc. operates globally as a healthcare company with two segments: Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health products and vaccines under various brands, while the Animal Health segment develops veterinary pharmaceuticals, vaccines, and health solutions. The company serves various customers including hospitals, government agencies, managed care providers, physicians, and pet owners. It has development agreements for ADC candidates with Daiichi Sankyos and AstraZeneca PLC, as well as collaborations with Eisai Co., Ltd., Bayer AG, Ridgeback Biotherapeutics LP, and Moderna, Inc.
| Indicator | Value |
|---|---|
| PER | 47.6 |
| EV/EBITDA | - |
| Price/Free Cash Flow' | 5.8 |
| ROIC | 10.2% |
| Net Debt/EBITDA | - |